This site uses modern web standards that aren't supported by your browser. For best results, please upgrade to Google Chrome, Microsoft Edge, or Mozilla Firefox.

The Road to Ten Million U.S. Patents and China’s Growing Influence


The Road to Ten Million U.S. Patents and China’s Growing Influence

|

Where am I - content-blog-article.php

The United States Patent and Trademark Office is rapidly approaching a significant milestone in its productive history of granting patents. Having issued the first patents back in 1790, the USPTO has, by virtue of its unique regulatory authority, been awarding patents to applicants at an increasingly furious pace and is rapidly approaching a tremendous milestone—the […]

Protecting Incentives to Innovate while Addressing Healthcare Costs

|

Where am I - content-blog-article.php

In a previous blog post, we reviewed key factors that drive the research, development, and pricing of prescription drugs. Drug research is extremely expensive and yields only about one successful medication for every 20 candidates in development. Those medications then have a limited period of patent protection in which to earn back the cost of that […]

Drug Companies Facing ‘Patent Cliff’

|

Where am I - content-blog-article.php

Baseball players are sometimes used to illustrate the elusive nature of success. Players who maintain a batting average of .300 throughout their careers – meaning they failed to get a hit 70 percent of the time – often are named to the sport’s hall of fame. If the pharmaceutical industry enjoyed a similarly lofty rate […]

Federal Jury Compares Patent Claims in Smartphone Case, Finds Apple and Samsung Infringed Patents

|

Where am I - content-blog-article.php

The latest round in the patent litigation of smartphone heavy weights Apple and Samsung ended with a split decision (mostly in Apple’s favor). A jury in San Jose, California federal court found last week that both companies infringed on each other’s patents, but the damages awarded were low compared to what was sought by both […]